| Host: |
Rabbit |
| Applications: |
WB/ELISA |
| Reactivity: |
Human/Rat/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Indoleamine 2, 3-dioxygenase 2 (101-150 aa) is suitable for use in Western Blot and ELISA research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-1:2000ELISA 1:20000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
IDO2 |
| Gene ID: |
169355 |
| Uniprot ID: |
I23O2_HUMAN |
| Immunogen Region: |
101-150 aa |
| Specificity: |
INDOL1 Polyclonal Antibody detects endogenous levels of INDOL1 protein. |
| Immunogen: |
The antiserum was produced against synthesized peptide derived from the Internal region of human IDO2 at the amino acid range 101-150 |
| Function | Catalyzes the first and rate limiting step of the catabolism of the essential amino acid tryptophan along the kynurenine pathway. Involved in immune regulation. May not play a significant role in tryptophan-related tumoral resistance. |
| Protein Name | Indoleamine 2 -3-Dioxygenase 2Ido-2Indoleamine 2 -3-Dioxygenase-Like Protein 1Indoleamine-Pyrrole 2 -3-Dioxygenase-Like Protein 1 |
| Database Links | Reactome: R-HSA-71240 |
| Alternative Antibody Names | Anti-Indoleamine 2 -3-Dioxygenase 2 antibodyAnti-Ido-2 antibodyAnti-Indoleamine 2 -3-Dioxygenase-Like Protein 1 antibodyAnti-Indoleamine-Pyrrole 2 -3-Dioxygenase-Like Protein 1 antibodyAnti-IDO2 antibodyAnti-INDOL1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
